BioSpace News Archive

Business

MTF Biologics Announces New Recovery Partner Relationship

MTF Biologics announced a new tissue recovery relationship with Southwest Transplant Alliance (STA) headquartered in Dallas, Tx. STA will begin recovering musculoskeletal and dermal tissues on behalf of MTF Biologics in February.

January 21, 2019
·
2 min read
Drug Development

Aurinia to Hold Conference Call and Webcast to Discuss Results of Phase 2 Head-to-Head Study of Voclosporin Ophthalmic Solution versus Restasis® for the Treatment of Dry Eye Syndrome

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP), a clinical stage biopharmaceutical company focused on the global immunology market, today announced it will report results before the opening of trading and hold a webcast and conference call to discuss the results of its Phase 2, double-masked, head-to-head study of VOS 0.2% versus Restasis

January 21, 2019
·
3 min read
BioMidwest

Enova Illumination Partners with Operation Smile to Provide Free and Discounted Surgical Headlights for Surgical Volunteers

Enova Illumination is happy to announce its support of Operation Smile by becoming a Business Ambassador.

January 21, 2019
·
2 min read
New Device that can Rapidly Diagnose Disease Could Save Lives

Monash University biospectroscopists have been issued a US patent for the diagnostic technology they hope will one day help doctors to diagnose and treat patients much faster than current pathology methods.

January 21, 2019
·
2 min read
Business

Valens Signs Multi-Year Cannabis Extraction Agreement with Sundial Growers

Valens GroWorks Corp.is pleased to announce that it has entered into a multi-year extraction services agreement (the “Agreement”) with privately-held Sundial Growers Inc. (“Sundial”) for cannabis extraction services.

January 21, 2019
·
4 min read
Biotech Bay

Lifestyle Choices May Help Glaucoma Patients Preserve Eyesight

American Academy of Ophthalmology offers advice on how people can take control of their health beyond medications and surgery

January 21, 2019
·
5 min read
Drug Development

TaiwanJ Pharmaceuticals Announces Positive Results from Phase 2 Orphan Drug Designation Study of JKB-122 on Autoimmune Hepatitis (AIH)

TaiwanJ Pharmaceuticals recently announced the results of phase II clinical trial of JKB-122 for the treatment of refractory Autoimmune Hepatitis (AIH) patients that demonstrated improvement on targeted objectives and relevant biomarkers from the JKB-122 treated subjects after the completion of 24-week study.

January 21, 2019
·
4 min read
Business

BD Board Declares Dividends Payable on March 29, 2019

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on March 29, 2019 to holders of record on March 8, 2019.

January 21, 2019
·
1 min read
Deals

Kindred Biosciences Announces Pricing of Public Offering of 4,215,000 Shares of its Common Stock

Kindred Biosciences, Inc. today announced the pricing of an underwritten public offering of 4,215,000 shares of its common stock at a public offering price of $9.50 per share

January 21, 2019
·
5 min read
Business

OCR and ImaBiotech initiate a strategic partnership to provide in situ drug efficacy and target exposure services in Pets with naturally occurring tumors

OCR and ImaBiotech have announced the launch of a new preclinical service for Biotech-Pharma-MedTech companies that allows drug efficacy and target exposure services at cellular level using Pets with naturally occurring tumors.

January 21, 2019
·
4 min read